Neuropsychologic testing for chemotherapy-related cognitive impairment

Advances in Experimental Medicine and Biology

Volumn 678, Issue , 2010, Pages 55-69

  Myers, Jamie S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CHEMOTHERAPY RELATED COGNITIVE IMPAIRMENT; COGNITIVE DEFECT; DEPTH PERCEPTION; EXECUTIVE FUNCTION; HUMAN; INFORMATION PROCESSING; LANGUAGE; LEARNING; MEMORY; MENTAL CONCENTRATION; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; CHEMICALLY INDUCED DISORDER; DRUG THERAPY;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; DRUG THERAPY; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 77956638888     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6306-2_9     Document Type: Review

References (33)

1. Ahles TA, Saykin A. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Inves 2001; 19:812-820. (Pubitemid 33151212)
2. Hess LM, Insel KC. Chemotherapy-related change in cognitive function: A conceptual model. Onco Nurs Forum 2007; 24:981-994.
3. Nail LM. Cognitive changes in cancer survivors. American J Nurs 2006; 106(3):48-54.
4. O'Shaughnessy J. Chemotherapy-related cognitive dysfunction in breast cancer. Semin Oncol Nurs 2003; 19(Supp 2):17-24.
5. Jansen C, Miaskowski C, Dodd M et al. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 2005; 32(6):1151-1161.
6. Freeman JR, Broshek DK. Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer Supplement 2002; 3(Suppl 3):S91-S99.
7. Ahles TA, Saykin A. Candidate mechanisms for chemotherapy-induced cognitive changes. Na Cancer Rev 2007; 7:192-201.
8. Cimprich B, So H, Ronis DL et al. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 2005; 14:70-78. (Pubitemid 40124675)
9. Jansen C, Miaskowski C, Dodd M et al. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 2007; 34:997-1005.
10. Brezden CB, Phillips KA, Abdollel M et al. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18:4175-4183.
11. Tchen N, Juffs HG, Downie FP et al. Cognitive function, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Oncol 2003; 21:4175-4183. (Pubitemid 46606186)
12. Vardy J, Wong K, Yi QL et al. Assessing cognitive function in cancer patients. Support Care Cancer 2006; 14:1111-1118. (Pubitemid 44898793)
13. Klemp JR, Stanton AL, Kimler BF et al. Evaluating the effects of chemotherapy on cognitive function and quality of life in premenopausal women with breast cancer. Paper presented at the San Antonio Breast Cancer Sympsoium 2006; San Antonio.
14. Wefel JS, Lenzi R, Theriault RL et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized longitudinal trial. Cancer 2004; 100:2292-2299. (Pubitemid 38657875)
15. Ahles TA, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer Supplement 2002; S84-S90.
16. Hensley ML, Correa DD, Thaler H et al. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecol Oncol 2006; 102:270-277. (Pubitemid 44063582)
17. Castellon SA, Ganz PA, Bower JE et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004; 26:955-969. (Pubitemid 39577316)
18. Cull A, Hay C, Love SB et al. What do cancer patients mean when they complain of concentration and memory problems. Br J Cancer 1996; 74:1674-1679. (Pubitemid 26386101)
19. Schagen SB, Muller MJ, Boogerd W et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 2002; 13(9):1387-1387.
20. Tannock IF, Ahles TA, Ganz PA et al. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Onco 2004; 22:2233-2239. (Pubitemid 41095159)
21. Jacobs SR, Jacobsen PB, Booth-Jones M et al. Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic stem cell transplant patients. J Pain Symptom Manage 2007; 33(1):13-23. (Pubitemid 46017075)
22. Freeman JR, Broshek DK. Assessing cognitive dysfunction in breast cancer: What are the tools? Clin Breast Cancer 2002; 3(Suppl 3):S91-S99.
23. Wefel JS, Lenzi R, Theriault R et al. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 2004; 101:466-475.
24. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007; 7(3):192-201.
25. Faust D, Fogel BS. The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 1989; 177(1):25-31. (Pubitemid 19043855)
26. Fogel BS. The high sensitivity cognitive screen. International Psychogeriatrics 1991; 3:273-288.
27. Erlanger DM, Feldman DJ, Kaplan D et al. Development and validation of the cognitive stability index, a Web-based protocol for monitoring change in cognitive function. Arch Clin Neuropsychol 2000; 15:693-694.
28. Erlanger DM, Kutner KC, Jacobs AR. Hormones and cognition: Current concepts and issues in neuropsychology. Neuropsych Rev 1999; 9(4):175-207. (Pubitemid 30065027)
29. Paraska KK, Bender CM. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: Two case studies. Oncol Nurs Forum 2003; 30:473-478.
30. Schagen SB, van Dam FS, Muller MJ et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999; 85:640-650. (Pubitemid 29075285)
31. van Dam FS, Schagen SB, Muller MJ et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998; 90:210-218. (Pubitemid 28114539)
32. Cimprich B, Ronis DL. Attention and symptom distress in women with and without breast cancer. Nurs Res 2001; 50(2):86-94. (Pubitemid 33603795)
33. Jenkins V, Shilling V, Deutsch G et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006; 94:828-834.